Exchange: NASDAQ·Updated 07:40 PM EDT
QNCX logo

QNCX Quince Therapeutics Inc

$31.92
$2.37
(8.07%)
Today
Closed $31.73
$0.19
(0.60%)
After Hours
EarningsNov 12
Mkt Cap$29.86M
Vol138,744.00

About QNCX

Quince Therapeutics, Inc. is a biopharmaceutical company, which engages in unlocking the power of a patient’s biology for the treatment of rare diseases. Its product includes eDSP, developed using their proprietary Autologous Intracellular Drug Encapsulation (AIDE) technology platform, which is a novel device combination that uses an automated process designed to encapsulate a drug into the patient’s own red blood cells. The company was founded by Casey Crawford Lynch, Stephen Dominy and Kristen Gafric on June 20, 2012 and is headquartered in South San Francisco, CA.
52

Neutral Sentiment

How do you feel about QNCX?

Bearwulf
$QNCX so far is doing pretty well all things considered wonder if we will get any news before 2027.
8
MedmanLAM001
$QNCX Highly undervalued! Could this be a safe haven in an unstable market? Amazing resilience!
1
5
RTPRwire
$QNCX is trading sharply higher on M&A / acquisition following a Globe Newswire release. Quince Therapeutics rebranded as IRulya Therapeutics following merger with Orphai Therapeutics, focusing on LAM-001 development for pulmonary diseases with $116M funding. RTPR pushed this release out to users at 8:00:00 AM ET
4
SierraIndiaDavid
$QNCX werent they looking for restructuring? They closed development on key product earlier this year. How are analyst starting to cover it now ?
6
rockstarjeremy
$QNCX Quince Therapeutics has rebranded as IRulya Therapeutics (effective October 12, 2026), shifting its ticker symbol on Nasdaq to “$IRLA”.
3
DipBuyPro
If you like to find the runners early - Join the group of bulls below One of the best FREE small cap communities i know of 🔥 🫡💯 Whales joining on $QNCX $DNA
2
focafoca99
$QNCX adopted new equity incentive plan and ESPP, and increased authorized shares to 275M after stockholder approval.
2
focafoca99
$QNCX named new directors and proposed stock issuance and authorized share increase at upcoming special meeting.
2

Advertisement|Remove ads.